Cargando…

Similar biological effects of different low doses of interferon alpha in cancer patients.

Detalles Bibliográficos
Autores principales:	Billard, C., Diez, R. A., Ferbus, D., Raynaud, N., Dorval, T., Pouillart, P., Nielsen, K., Falcoff, E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1987
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002051/ https://www.ncbi.nlm.nih.gov/pubmed/3620312

Ejemplares similares

Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects
por: Schlaepfer, Erika, et al.
Publicado: (2019)

Different Biological Activities of Specific Interferon Alpha Subtypes
por: Hasenkrug, Kim J., et al.
Publicado: (2019)

Effect of Low-Dose Human Interferon-alpha on Shipping Fever of Thoroughbred Racehorses
por: AKAI, Makoto, et al.
Publicado: (2009)

Reply to Hasenkrug et al., “Different Biological Activities of Specific Interferon Alpha Subtypes”
por: Schlaepfer, Erika, et al.
Publicado: (2019)

Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancer.
por: Fiorentino, B., et al.
Publicado: (1992)

Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor
Publicado: (1984)

Postirradiation Sarcoma: Clinicopathologic Features and Role of Chemotherapy in the Treatment Strategy
por: des Guetz, Gaetan, et al.
Publicado: (2009)

Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma
por: Furuya, Nobutaka, et al.
Publicado: (2011)

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.
por: Ravaud, A., et al.
Publicado: (1994)

Development of a murine animal model of depression for repeated dosing with human interferon alpha
por: Siddegowda, Nagesh Koregala, et al.
Publicado: (2011)

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010)

Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells
por: Tsaur, Igor, et al.
Publicado: (2015)

Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998)

Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha
por: Gomez-Lucia, Esperanza, et al.
Publicado: (2019)

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma.
por: Kruit, W. H., et al.
Publicado: (1996)

Survival, response and immune effects in a prospectively randomized study of dose strategy for alpha-N1 interferon.
por: Silver, H. K., et al.
Publicado: (1988)

Interferon Alpha Association with Neuromyelitis Optica
por: Asgari, Nasrin, et al.
Publicado: (2013)

Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
por: Melki, Ronald
Publicado: (2015)

Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.
por: Tank, B., et al.
Publicado: (1984)

Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet’s Syndrome with refractory vascular or neurological involvement: a case series
por: Sun, Luxi, et al.
Publicado: (2022)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
por: Wittling, Megen C., et al.
Publicado: (2021)

Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.
por: Scholl, S. M., et al.
Publicado: (1994)

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.
por: Tartour, E., et al.
Publicado: (1994)

Low Serum Levels of Interferon Alpha in COVID-19 Patients Are Associated with Older Age
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2022)

Failure of high doses of alpha interferon to affect the growth of human carcinoma, melanoma, and myeloid leukaemia xenografts.
por: Clutterbuck, R. D., et al.
Publicado: (1983)

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2019)

Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent
por: Hillyer, P, et al.
Publicado: (2013)

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study
por: Verdegaal, Els, et al.
Publicado: (2020)

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005)

Las actividades físicas y deportivas : enseñar, estimular, entrenar /
por: Pouillart, G.
Publicado: (1989)

Comparison of the effects of low dose interferon and high dose interferon on reduction of the number and size of plaques in patients with Multiple Sclerosis: A historical cohort
por: Khomand, Payam, et al.
Publicado: (2017)

Interferon-alpha-Induced Changes in NODDI Predispose to the Development of Fatigue
por: Dowell, N.G., et al.
Publicado: (2019)

Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta
Publicado: (1988)

Adding Low-Dose Propofol to Limit Anxiety during Target-Controlled Infusion of Remifentanil for Gastrointestinal Endoscopy: Respiratory Issues and Safety Recommendations
por: Motamed, Cyrus, et al.
Publicado: (2022)

The Biology of the Interferon System
por: Werenne, John
Publicado: (1983)

Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice
por: Ravaud, A, et al.
Publicado: (1999)

Major combined electrolyte deficiency during therapy with low-dose Cisplatin, 5-Fluorouracil and Interferon alpha: report on several cases and review of the literature [ISRCTN62866759]
por: Hoffmann, Katrin, et al.
Publicado: (2006)

Low‐dose oral interferon alpha as prophylaxis against viral respiratory illness: a double‐blind, parallel controlled trial during an influenza pandemic year
por: Bennett, Alayne L., et al.
Publicado: (2013)

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_iosajhl3qoc1fh6ijit6c51uib